BRIAN GASSER: Open Payments
NPI 1194744615 · NEPHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 95 payments from 17 companies in 2025. Trend: 2023 $1,287 · 2024 $2,314 · 2025 $1,579
Food & beverage: $1,479Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $250 |
| PFIZER INC. | 11 | $189 |
| Janssen Biotech, Inc. | 8 | $184 |
| LEO Pharma Inc. | 7 | $177 |
| UCB, Inc. | 6 | $164 |
| Novartis Pharmaceuticals Corporation | 17 | $154 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $146 |
| GENZYME CORPORATION | 3 | $77 |
| Lilly USA, LLC | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: SKYRIZI, TREMFYA, Bimzelx, ADBRY, LITFULO, ILUMYA, COSENTYX, CIBINQO.
Industry payments across UT — which companies pay providers there.
